Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dag Morten Dalen

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 15, 2006
Price regulation and generic competition in the pharmaceutical marketDag Morten Dalen, Steinar Strøm, Tonje Haabeth
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 10, 2010
Generic substitution: micro evidence from register data in NorwayDag Morten Dalen, Kari Furu, Marilena Locatelli, et al.
Journal of Health Economics|March 22, 2022
Paying for pharmaceuticals: uniform pricing versus two-part tariffsKurt R Brekke, Dag Morten Dalen, Odd Rune Straume
Journal of Health Economics|June 23, 2026
Competition matters: Uniform vs. indication-based pricing of pharmaceuticalsKurt R Brekke, Dag Morten Dalen, Odd Rune Straume
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 23, 2013
Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugsKurt Richard Brekke, Dag Morten Dalen, Tor Helge Holmås
Journal of Health Economics|March 8, 2025
Taking the competitor's pill: When combination therapies enter pharmaceutical marketsKurt R Brekke, Dag Morten Dalen, Odd Rune Straume
Journal of Health Economics|June 21, 2023
The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical marketsKurt R Brekke, Dag Morten Dalen, Odd Rune Straume
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|July 15, 2006
Price regulation and generic competition in the pharmaceutical marketDag Morten Dalen, Steinar Strøm, Tonje Haabeth
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|March 10, 2010
Generic substitution: micro evidence from register data in NorwayDag Morten Dalen, Kari Furu, Marilena Locatelli, et al.
Journal of Health Economics|March 22, 2022
Paying for pharmaceuticals: uniform pricing versus two-part tariffsKurt R Brekke, Dag Morten Dalen, Odd Rune Straume
Journal of Health Economics|June 23, 2026
Competition matters: Uniform vs. indication-based pricing of pharmaceuticalsKurt R Brekke, Dag Morten Dalen, Odd Rune Straume
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care|October 23, 2013
Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugsKurt Richard Brekke, Dag Morten Dalen, Tor Helge Holmås
Journal of Health Economics|March 8, 2025
Taking the competitor's pill: When combination therapies enter pharmaceutical marketsKurt R Brekke, Dag Morten Dalen, Odd Rune Straume
Journal of Health Economics|June 21, 2023
The price of cost-effectiveness thresholds under therapeutic competition in pharmaceutical marketsKurt R Brekke, Dag Morten Dalen, Odd Rune Straume
Pageof 1